טוען...
(18)F-FDG-PET/CT for Systemic Staging of Newly Diagnosed Triple-Negative Breast Cancer
PURPOSE: National Comprehensive Cancer Network guidelines recommend (18)F-FDG-PET/CT, in addition to standard staging procedures, for systemic staging of newly diagnosed stage III breast cancer patients. However factors in addition to stage may influence PET/CT utility. As breast cancers that are ne...
שמור ב:
| הוצא לאור ב: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5480318/ https://ncbi.nlm.nih.gov/pubmed/27129866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3402-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|